solubl receptor agent serum-medi suppress human viscer leishmaniasi viscer leishmaniasi VL patient lymphocyt leishmania Ag stimul sera exhibit potent nonspecif suppress effect respons normal lymphocyt sera VL patient patient subclin VL normal volunt sera VL patient con a-induc lymphocyt prolif respons ifn-gamma product normal lymphocyt addit exogen human cultur VL patient sera normal lymphocyt prolif capac ifn-gamma product phenomenon consist presenc elev level solubl VL patient sera u/ml normal sera u/ml sera patient subclin leishmania infect immunosuppress u/ml remov VL serum suppress activ effect ifn-gamma product data particip high level serum-medi suppress VL 